Wisconsin Set to Ban Non-FDA Approved Vapes Starting September, Court Ruling Pending

Aug.27.2025
Wisconsin Set to Ban Non-FDA Approved Vapes Starting September, Court Ruling Pending
Wisconsin is planning to prohibit the sale of all vape products that have not been approved by the U.S. Food and Drug Administration (FDA) starting September 1. At present, WISCOFAST, a non-profit trade association formed by vape shop owners, has filed a lawsuit against the state government in an attempt to block the law from taking effect. The court is expected to rule later this week on whether the ban will be enforced.

Key Points

  • Timeline: The ban is scheduled to take effect on September 1, with only FDA-approved non-nicotine or menthol products allowed for sale.
  • Legal Dispute: WISCOFAST, representing vape shop owners, has filed a lawsuit against the Wisconsin Department of Revenue Secretary. The case has entered federal court proceedings.
  • Business Concerns: The ban may cause thousands of vape shops to close, increase unemployment, and reduce the state’s tax revenue.
  • Penalties: Retailers who sell banned products may face fines of US$1,000 per SKU per day.
  • Economic Impact: Businesses expect Wisconsin to lose millions of dollars in tax revenue, with widespread closures and fewer choices for consumers.

 


 

【2Firsts News Flash】According to WDIO on August 27, Wisconsin lawmakers plan to prohibit the sale of all non-FDA-approved vape products starting on September 1 (Labor Day). The measure has triggered strong opposition from small businesses. WISCOFAST, the Wisconsin trade association representing vape shop owners, has filed a lawsuit in federal court in an effort to block the law from taking effect. The court is expected to rule later this week on whether the ban will proceed.

 

WISCOFAST founder Tyler Hall stated that once the ban is implemented, thousands of vape shops across the state will be severely impacted:

 

“Vape shops in the state are no longer going to be able to sell the traditional vape products that they’ve used for the last over a decade.”

 

According to the law, only FDA-approved non-nicotine or menthol e-cigarette products may be sold in Wisconsin. Hall pointed out that the current list of FDA-approved products does not include any flavored vapes.

 

Tim Frey, spokesperson for Ignite Dispensary, said that if the ban takes effect, he will have to pull almost all of his products from the shelves or face hefty fines:

 

“It’s a $1,000 fine per day per SKU. For example, even if I’ve got just one flavor from one brand with five different nicotine strengths, that counts as five different SKUs. Violating the law for one day could mean thousands of dollars in fines.”

 

Frey further added that the ban would result in millions of dollars in lost annual tax revenue for Wisconsin, while also leading to store closures, job losses, and fewer options for consumers.

 

“Out of roughly 3,000 stores statewide, more than half of them will probably shut down.”

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei Industrial Co., Ltd. disclosed several oral nicotine-related patent applications in August 2026, including two that approach staged nicotine release from different directions. One uses a high-viscosity membrane that forms inside the pouch after contact with saliva to slow rapid early release, while the other uses gradient particles with a faster-disintegrating outer layer and a slower core to create a fast-to-sustained release profile. Together, the filings explore how nicotine pouches could balance initial delivery with release later in use.
Sep.03
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
The HQD SiSA 80K Hookah Disposable Vape has appeared across U.S. and cross-border online retail channels. The device comes prefilled with 28ml of e-liquid, uses a 5% nicotine salt configuration and carries a brand claim of up to 80,000 puffs. Beyond puff count, the product differentiates itself through hookah-inspired features including adjustable airflow, a flowing-water sound effect and flavor options associated with traditional hookah consumption.
Aug.18
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives